Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Artelo Biosciences, Inc. (ARTL) had Weighted-Average Shares Outstanding (Diluted) of 0.74M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-2.96M |
|
-- |
|
-- |
|
$2.69M |
|
$-2.69M |
|
$-0.27M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.96M |
|
$-2.69M |
|
$-2.60M |
|
0.74M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.74M |
$-4.00 |
|
$-4.00 |
|
| Balance Sheet Financials | |
$10.42M |
|
-- |
|
$2.10M |
|
$12.52M |
|
$5.83M |
|
-- |
|
$0.02M |
|
$5.85M |
|
$6.67M |
|
$4.63M |
|
$6.67M |
|
0.88M |
|
| Cash Flow Statement Financials | |
$-1.19M |
|
-- |
|
$10.86M |
|
$0.60M |
|
$10.27M |
|
$9.67M |
|
$0.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.79 |
|
-- |
|
-- |
|
-- |
|
0.10 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.19M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-44.33% |
|
-63.85% |
|
-23.63% |
|
-44.33% |
|
$7.62 |
|
$-1.61 |
|
$-1.61 |
|